|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 | |
| C07K 16/28 | |||
| C07K 16/46 |
| (11) | Number of the document | 3174901 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15756479.0 |
| Date of filing the European patent application | 2015-07-31 | |
| (97) | Date of publication of the European application | 2017-06-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2015/055815 |
| Date | 2015-07-31 |
| (87) | Number | WO 2016/016859 |
| Date | 2016-02-04 |
| (30) | Number | Date | Country code |
| 201462031784 P | 2014-07-31 | US |
| (72) |
RATTEL, Benno, DE
FRIEDRICH, Matthias, DE
KUFER, Peter, DE
HOFFMANN, Patrick, DE
RAUM, Tobias, DE
MUNZ, Markus, DE
HERRMANN, Ines, DE
LUTTERBUESE, Ralf, DE
NAHRWOLD, Elisabeth, DE
|
| (73) |
Amgen Research (Munich) GmbH,
Staffelseestrasse 2, 81477 München,
DE
|
| (54) | OPTIMIZED CROSS-SPECIES SPECIFIC BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCTS |
| OPTIMIZED CROSS-SPECIES SPECIFIC BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCTS |